EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $446,000 | +4.4% | 36,453 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $427,000 | -29.7% | 36,066 | +13.1% | 0.00% | 0.0% |
| Q1 2022 | $607,000 | +41.5% | 31,889 | +97.5% | 0.00% | 0.0% |
| Q4 2021 | $429,000 | -36.0% | 16,144 | -1.0% | 0.00% | -33.3% |
| Q3 2021 | $670,000 | -27.5% | 16,311 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $924,000 | +8.6% | 16,311 | -19.5% | 0.00% | 0.0% |
| Q1 2021 | $851,000 | -68.8% | 20,251 | -47.9% | 0.00% | -66.7% |
| Q4 2020 | $2,724,000 | +112.6% | 38,852 | -14.9% | 0.01% | +100.0% |
| Q3 2020 | $1,281,000 | -27.3% | 45,642 | -23.3% | 0.01% | -25.0% |
| Q2 2020 | $1,761,000 | +41.9% | 59,532 | -4.9% | 0.01% | 0.0% |
| Q1 2020 | $1,241,000 | -28.3% | 62,602 | +7.0% | 0.01% | -11.1% |
| Q4 2019 | $1,732,000 | +451.6% | 58,497 | +360.4% | 0.01% | +350.0% |
| Q2 2019 | $314,000 | -28.3% | 12,705 | -29.1% | 0.00% | 0.0% |
| Q1 2019 | $438,000 | – | 17,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |